E-cigarettes: a draw for pharma?
This article was originally published in Scrip
The UK MHRA has certainly caused a splash with its announcement of plans to regulate e-cigarettes as medicines. But in fact it is only pre-empting a measure that is already on the way courtesy of the draft EU tobacco Directive, which is due to be discussed by member state health ministers on 21 June.
You may also be interested in...
The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.
Health ministers have called for more action on access to medicines, including a new EU work agenda, rebuilding Europe’s manufacturing capabilities, further action on pricing, and greater leeway for member states to mitigate drug shortages by restricting parallel exports.